MR imaging in ovarian cancer

Cancer of the Ovary

Volumn , Issue , 2006, Pages 112-131

  Sohaib, Aslam ^a   Reznek, Rodney ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79954940494     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545887.009     Document Type: Chapter

References (59)

1. R. Bammer and S. O. Schoenberg. Current concepts and advances in clinical parallel magnetic resonance imaging. Top Magn Reson Imaging (2004), 15:129–58.
2. R. Forstner, H. Hricak, K. A. Occhipinti, et al. Ovarian cancer: staging with CT and MR imaging. Radiology (1995), 197:619–26.
3. R. N. Low and J. S. Signeti. MR imaging of peritoneal disease. AJR Am J Roentgenol (1994), 163:1131–40.
4. M. A. Ghossain, J. N. Buy, C. Ligneres, et al. Epithelial tumors of the ovary: comparison of MR and CT findings. Radiology (1991), 181:863–70.
5. S. Thurnher, J. Hodler, S. Baer, et al. Gadolinium-DOTA enhanced MR imaging of adnexal tumors. J Comput Assist Tomogr (1990), 14:939–49.
6. S. A. Sohaib, A. Sahdev, P. O. Van Trappen, et al. Characterization of adnexal mass lesions on MR imaging. AJR Am J Roentgenol (2003), 180:1297–304.
7. M. Katayama, T. Masui, S. Kobayashi, et al. Diffusion-weighted echo planar imaging of ovarian tumors: is it useful to measure apparent diffusion coefficients? J Comput Assist Tomogr (2002), 26:250–6.
8. K. Kinkel, H. Hricak, Y. Lu, et al. US characterization of ovarian masses: a meta-analysis. Radiology (2000), 217:803–11.
9. P. P. Koonings, K. Campbell, D. R. Mishell Jr, et al. Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol (1989), 74:921–6.
10. S. A. Sohaib, T. D. Mills, A. Sahdev, et al. The role of magnetic resonance imaging and ultrasound in patients with adnexal masses. Clin Radiol (2005), 60:340–8.
11. Y. Yamashita, M. Torashima, Y. Hatanaka, et al. Adnexal masses: accuracy of characterization with transvaginal US and precontrast and postcontrast MR imaging. Radiology (1995), 194:557–65.
12. T. Komatsu, I. Konishi, M. Mandai, et al. Adnexal masses: transvaginal US and gadolinium-enhanced MR imaging assessment of intratumoral structure. Radiology (1996), 198:109–15.
13. A. Rieber, K. Nussle, I. Stohr, et al. Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings. AJR Am J Roentgenol (2001), 177:123–9.
14. K. Kinkel, Y. Lu, A. Mehdizade, et al. Indeterminate ovarian mass at US: incremental value of second imaging test for characterization–meta-analysis and Bayesian analysis. Radiology (2005), 236:85–94.
15. S. K. Stevens, H. Hricak and J. L. Stern. Ovarian lesions: detection and characterization with gadolinium-enhanced MR imaging at 1.5 T. Radiology (1991), 181:481–8.
16. R. C. Semelka, P. H. Lawrence, J. P. Shoenut, et al. Primary ovarian cancer: prospective comparison of contrast-enhanced CT and pre- and post-contrast, fat-suppressed MR imaging, with histologic correlation. J Magn Reson Imaging (1993), 3:99–106.
17. H. Hricak, M. Chen, F.V. Coakley, et al. Complex adnexal masses: detection and characterization with MR imaging – multivariate analysis. Radiology (2000), 214:39–46.
18. R. Forstner, H. Hricak and S. White. CT and MRI of ovarian cancer. Review. Abdom Imaging (1995), 20:2–8.
19. J. N. Buy, M. A. Ghossain, C. Sciot, et al. Epithelial tumors of the ovary: CT findings and correlation with US. Radiology (1991), 178:811–8.
20. R. N. Troiano, K. M. Lazzarini, L. M. Scoutt, et al. Fibroma and fibrothecoma of the ovary: MR imaging findings. Radiology (1997), 204:795–8.
21. E. K. Outwater, E. S. Siegelman, A. Talerman, et al. Ovarian fibromas and cystadenofibromas: MRI features of the fibrous component. J Magn Reson Imaging (1997), 7:465–71.
22. K. Togashi, K. Nishimura, I. Kimura, et al. Endometrial cysts: diagnosis with MR imaging. Radiology (1991), 180:73–8.
23. Y.O. Tanaka, T. Yoshizako, M. Nishida, et al. Ovarian carcinoma in patients with endometriosis: MR imaging findings. AJR Am J Roentgenol (2000), 175:1423–30.
24. J. M. Heaps, R. K. Nieberg and J. S. Berek. Malignant neoplasms arising in endometriosis. Obstet Gynecol (1990), 75:1023–8.
25. D. S. McMeekin, R. A. Burger, A. Manetta, et al. Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis. Gynecol Oncol (1995), 59:81–6.
26. N. M. De Souza, R. O’Neill, G. A. McIndoe, et al. Borderline tumors of the ovary: CT and MRI features and tumor markers in differentiation from stage I disease. AJR Am J Roentgenol (2005), 184:999–1003.
27. S. K. Stevens, H. Hricak and Z. Campos. Teratomas versus cystic hemorrhagic adnexal lesions: differentiation with proton-selective fat-saturation MR imaging. Radiology (1993), 186:481–8.
28. S. H. Kim, Y. J. Kim, B. K. Park, et al. Collision tumors of the ovary associated with teratoma: clues to the correct preoperative diagnosis. J Comput Assist Tomogr (1999), 23:929–33.
29. S. E. Rha, J. Y. Byun, S. E. Jung, et al. Atypical CT and MRI manifestations of mature ovarian cystic teratomas. AJR Am J Roentgenol (2004), 183:743–50.
30. J. T. Comerci Jr, F. Licciardi, P. A. Bergh, et al. Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature. Obstet Gynecol (1994), 84:22–8.
31. A. Kido, K. Togashi, I. Konishi, et al. Dermoid cysts of the ovary with malignant transformation: MR appearance. AJR Am J Roentgenol (1999), 172:445–9.
32. Y. O. Tanaka, Y. Kurosaki, M. Nishida, et al. Ovarian dysgerminoma: MR and CT appearance. J Comput Assist Tomogr (1994), 18:443–8.
33. S. H. Kim and S. B. Kang. Ovarian dysgerminoma: color Doppler ultrasonographic findings and comparison with CT and MR imaging findings. J Ultrasound Med (1995), 14:843–8.
34. S. E. Jung, S. E. Rha, J. M. Lee, et al. CT and MRI findings of sex cord-stromal tumor of the ovary. AJR Am J Roentgenol (2005), 185:207–15.
35. J. E. MacSweeney and D. M. King. Computed tomography, diagnosis, staging and follow-up of pure granulosa cell tumour of the ovary. Clin Radiol (1994), 49:241–5.
36. R. K. Schwartz, D. Levine, H. Hatabu, et al. Ovarian fibroma: findings by contrast-enhanced MRI. Abdom Imaging (1997), 22:535–7.
37. S. K. Stevens. The adnexa. In: Higgins, C. B., Hricak, H., Helms, C. A. eds., Magnetic Resonance Imaging of the Body, 2nd edn. (New York: Raven Press Ltd, 1992), pp. 865–89.
38. D. L. Brown, K. H. Zou, C. M. Tempany, et al. Primary versus secondary ovarian malignancy: imaging findings of adnexal masses in the Radiology Diagnostic Oncology Group Study. Radiology (2001), 219:213–8.
39. E. K. Outwater and C. J. Dunton. Imaging of the ovary and adnexa: clinical issues and applications of MR imaging. Radiology (1995), 194:1–18.
40. D. G. Mitchell, M. C. Hill, S. Hill, et al. Serous carcinoma of the ovary: CT identification of metastatic calcified implants. Radiology (1986), 158:649–52.
41. R. N. Low, W. D. Carter, F. Saleh, et al. Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT. Radiology (1995), 195:391–400.
42. L. M. Payer, R. Stiglbauer, J. Kramer, et al. Superparamagnetic particles as oral contrast medium in MRI of patients with treated ovarian cancer – comparison with plain MRI. Br J Radiol (1993), 66:415–9.
43. M. E. Potter, E. E. Partridge, K. D. Hatch, et al. Primary surgical therapy of ovarian cancer: how much and when. Gynecol Oncol (1991), 40:195–200.
44. J. W. Walsh. Computed tomography of gynaecologic neoplasms. Radiol Clin North Am (1992), 30:817–30.
45. F. V. Coakley. Staging ovarian cancer: role of imaging. Radiol Clin North Am (2002), 40:609–36.
46. A. C. Fleischer. Transabdominal and transvaginal songraphy of ovarian masses. Clin Obstet Gynecol (1991), 34:433–42.
47. R. C. Sanders, B. J. McNeil, H. J. Finberg, et al. A prospective study of computed tomography and ultrasound in the detection and staging of pelvic masses. Radiology (1983), 146:439–42.
48. R. A. Shiels, K. R. Peel, H. N. MacDonald, et al. A prospective trial of CT in staging of ovarian malignancy. Br J Obstet Gynaecol (1985), 92:407–12.
49. R. J. Johnson, G. Blackledge, B. Eddleston, et al. Abdomino-pelvic computed tomography in the management of ovarian carcinoma. Radiology (1983), 146:447–52.
50. R. M. Blaquiere and J. E. Husband. Conventional radiology and computed tomography in ovarian cancer: discussion paper. J R Soc Med (1983), 76:574–9.
51. J. I. Meyer, A. W. Kennedy, R. Friedman, et al. Ovarian carcinoma: value of CT in predicting success of debulking surgery. AJR Am J Roentgenol (1995), 165:875–8.
52. B. E. Nelson, A. T. Rosenfield and P. E. Schwartz. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol (1993), 11:166–72.
53. R. N. Low, B. Duggan, R. M. Barone, et al. Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year. Radiology (2005), 235:918–26.
54. L. Prayer, C. Kainz, J. Kramer, et al. CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer. J Comput Assist Tomogr (1993), 17:626–32.
55. A. Goldhirsch, J. K. Triller, R. Greiner, et al. Computed tomography prior to second-look operation in advanced ovarian cancer. Obstet Gynecol (1983), 62:630–4.
56. E. Moskovic, I. Fernando, P. Blake, et al. Lymphography - current role in oncology. Br J Radiol (1991), 64:422–7.
57. P. M. Silverman, M. Osborne, N. R. Dunnick, et al. CT prior to second-look operation in ovarian cancer. AJR Am J Roentgenol (1988), 150:829–32.
58. R. Forstner, H. Hricak, C. B. Powell, et al. Ovarian cancer recurrence: value of MR imaging. Radiology (1995), 196:715–20.
59. R. N. Low, F. Saleh, S. Y. Song, et al. Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination – a longitudinal study. Radiology (1999), 211:519–28.